SCHEMBL4411615

SCHEMBL4411615

O=Cc1ccc(-c2ccc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.57
AKR1C2 P52895 2/20 0.57
KIF11 P52732 1/20 0.53
ALOX5AP P20292 2/20 0.43
FEN1 P39748 2/20 0.43
CES2 O00748 2/20 0.42
EDNRB P24530 1/20 0.41
EDNRA P25101 1/20 0.41
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
DRD1 P21728 3/20 0.37
APP P05067 1/20 0.37
CYP2C9 P11712 1/20 0.37
SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18001814 0.87 KIF11 (0.57) AKR1C3AKR1C2KIF11CES2PSEN1
SCHEMBL24409095 0.86 AKR1C3 (0.54) AKR1C3AKR1C2KIF11
SCHEMBL4418949 0.83 APP (0.54) AKR1C3AKR1C2KIF11ALOX5APFEN1
SCHEMBL18001934 0.83 AKR1C3 (0.57) AKR1C3AKR1C2KIF11DRD1DRD2
SCHEMBL31227778 0.83 AKR1C3 (0.47) AKR1C3AKR1C2KIF11ALOX5APFEN1
SCHEMBL23226467 0.82 GRM2 (0.44) AKR1C3AKR1C2KIF11ALOX5APFEN1
SCHEMBL21358553 0.80 AKR1C3 (0.51) AKR1C3AKR1C2KIF11
SCHEMBL18002472 0.80 AHR (0.43) AKR1C3AKR1C2KIF11ALOX5APFEN1
SCHEMBL17508160 0.80 KIF11 (0.53) AKR1C3AKR1C2KIF11ALOX5APFEN1
SCHEMBL17508177 0.79 IL2 (0.49) AKR1C3AKR1C2KIF11DRD1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016019588-A1 OXACAZONE COMPOUNDS TO TREAT CLOSTRIDIUM DIFFICILE THE BROAD INSTITUTE, INC. (US) 2016-02-11 WO disclosed
WO-2016019588-A1 OXACAZONE COMPOUNDS TO TREAT CLOSTRIDIUM DIFFICILE THE BROAD INSTITUTE, INC. (US) 2016-02-11 WO disclosed
EP-1479671-B1 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2009-05-27 EP disclosed
US-7115616-B2 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2006-10-03 US disclosed
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 US disclosed